Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Clin Chem. 2015 Nov 19;62(1):252–261. doi: 10.1373/clinchem.2015.245860

Fig. 4. NSCLC tissue expression for each of the targets in a multiplex SRM analysis, sorted by K7 expression from low to high, left to right.

Fig. 4

The 15 samples represent a mixture of 13 ALK rearrangement positive controls and 2 ROS1 rearrangement positive controls. Note that DH12 showed an increased expression of MET (highlighted in yellow).